STAT January 5, 2026
Ed Silverman, Elaine Chen

Prepare for some twists and turns when it comes to drugmakers

A new year always brings new challenges, and there will be many of them facing the pharmaceutical industry and policymakers in 2026 as Americans continue to clamor for affordable medicines that deliver relief and cures.

Meeting those challenges is no easy task, though, given the complexities of drug development,...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma, Pharma / Biotech
What’s new with GLP-1s
Podcast: Medicaid vs. 340B: A Drug Pricing Clash (Sayeh Nikpay)
283: A candid conversation: Physicians on the front lines of GLP‑1 care
BigHat, Revvity Collaborate with Eli Lilly, Immunai Signs Agreement with Bristol Myers Squibb, SandboxAQ Launches New AI Model
Medicare Is Covering GLP-1s – It’s Time to Cover the Care That Makes Them Sustainable

Share Article